Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
8.48
-0.12 (-1.40%)
At close: Aug 28, 2026, 4:00 PM EDT
8.60
+0.12 (1.42%)
After-hours: Aug 28, 2026, 7:57 PM EDT
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $1.55 billion as of August 28, 2026. Its market cap has increased by 19.83% in one year.
Market Cap
1.55B
Enterprise Value
1.71B
1-Year Change
19.83%
Ranking
Category
Stock Price
$8.48
ChartMarket Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $1.55B, an increase of 422.72%. That is a compound annual growth rate of 40.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 1.55B | 18.70% |
| Dec 31, 2025 | 1.30B | 157.72% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
| Oct 6, 2021 | 295.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bausch Health Companies | 2.36B |
| Trulieve Cannabis | 2.28B |
| HUTCHMED (China) | 2.13B |
| Perrigo Company | 2.01B |
| Alvotech | 1.77B |
| Eton Pharmaceuticals | 1.71B |
| ANI Pharmaceuticals | 1.56B |
| Phibro Animal Health | 1.53B |